Elevance Health said on January 23, 2024 that its Audit Committee of the Board of Directors declared a quarterly cash dividend of $1.63 per share.

8-KOther EventsFiled Jan 25, 2024Period of report Jan 23, 2024Summary published (UTC) Oct 31, 2026

Key points

AI summary

Elevance Health said on January 23, 2024 that its Audit Committee of the Board of Directors declared a quarterly cash dividend of $1.63 per share.
The company said the quarterly dividend is payable on March 22, 2024.
The company said the dividend will be paid to shareholders of record as of March 8, 2024.
The company said it disclosed the dividend declaration under Item 8.01 (Other Events) of Form 8-K, and that the report was signed on January 25, 2024.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Declares $1.63 Quarterly Cash Dividend

Elevance Health said on January 23, 2024 that its Audit Committee of the Board of Directors declared a quarterly cash dividend of $1.63 per share.

Source · Based on the filing body and exhibits

Dividend Payable on March 22, 2024

The company said the quarterly dividend is payable on March 22, 2024.

Source · Based on the filing body and exhibits

Dividend Record Date March 8, 2024

The company said the dividend will be paid to shareholders of record as of March 8, 2024.

Source · Based on the filing body and exhibits

Discloses Dividend Under Item 8.01 Other Events

The company said it disclosed the dividend declaration under Item 8.01 (Other Events) of Form 8-K, and that the report was signed on January 25, 2024.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.